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Traumatic spinal cord injury (SCI) results in the formation of a ﬁbrous scar acting as a
growth barrier for regenerating axons at the lesion site.We have previously shown (Klapka
et al., 2005) that transient suppression of the inhibitory lesion scar in rat spinal cord leads
to long distance axon regeneration, retrograde rescue of axotomized cortical motoneu-
rons, and improvement of locomotor function. Here we applied a systemic approach to
investigate for the ﬁrst time speciﬁc and dynamic alterations in the cortical gene expres-
sion proﬁle following both thoracic SCI and regeneration-promoting anti-scarring treatment
(AST). In order tomonitor cortical gene expressionwe carried outmicroarray analyses using
total RNA isolated from layer V/VI of rat sensorimotor cortex at 1–60 days post-operation
(dpo).We demonstrate that cortical neurons respond to injury by massive changes in gene
expression, starting as early as 1 dpo. AST, in turn, results in profound modiﬁcations of the
lesion-induced expression proﬁle. The treatment attenuates SCI-triggered transcriptional
changes of genes related to inhibition of axon growth and impairment of cell survival,
while upregulating the expression of genes associated with axon outgrowth, cell protec-
tion, and neural development.Thus, AST not only modiﬁes the local environment impeding
spinal cord regeneration by reduction of ﬁbrous scarring in the injured spinal cord, but,
in addition, strikingly changes the intrinsic capacity of cortical pyramidal neurons toward
enhanced cell maintenance and axonal regeneration.
Keywords: anti-scarring treatment, axonal regeneration, axotomy, corticospinal tract, lesion scar, microarray,
sensorimotor cortex, spinal cord injury
INTRODUCTION
Corticospinal tract (CST) axotomy permanently deprives the
motoneurons in layer V of the sensorimotor cortex of their func-
tions in locomotor control. Possible reasons for regeneration fail-
ure of injured axons in the central nervous system (CNS) are
the lack of growth-promoting factors (Houweling et al., 1998),
the presence of inhibitory cues like the myelin proteins Nogo-
A, myelin-associated glycoprotein (MAG), and oligodendrocyte-
myelin glycoprotein (OMGP; McKerracher and Winton, 2002;
Filbin, 2003), as well as the lesion scar (Fawcett and Asher, 1999;
Klapka and Müller, 2006). The latter growth barrier consists of a
collagen type IV network (basement membrane) which accumu-
lates inhibitory molecules (Yurchenco and Schittny, 1990; Timpl,
1994) such as chondroitin sulfate proteoglycans (CSPG, Snow
et al., 1990; Jones et al., 2002; Morgenstern et al., 2002; Davies
et al., 2004), semaphorins (de Winter et al., 2002; Niclou et al.,
2003), and ephrins (Bundesen et al., 2003) thereby preventing
axonal regeneration across the lesion site.
Although several studies investigated the gene expression
response in the CNS after brain injury (Salin and Chesselet, 1992;
Abankwa et al., 2002; Bareyre et al., 2002; Raghavendra Rao et al.,
2003; Küry et al., 2004; Poulsen et al., 2005; Israelsson et al., 2006),
only little is known about the transcriptional response in affected
brain regions following spinal cord injury (SCI). Most studies
suggest that CNS neurons differ in their response to axotomy
compared to PNS neurons as exempliﬁed by analyses done on
growth-associated protein 43 (Gap43) and α-tubulin (Mikucki
and Oblinger, 1991; Tetzlaff et al., 1994; Fournier and McKer-
racher, 1997). Data of Mason et al. (2003) further suggest that cor-
tical neurons show variations in axotomy-induced gene expression
depending on the distance of the injury site to the cell body. The
authors identiﬁed increased expression of a number of growth-
associated genes such as the oncogene c-jun/ap-1, l1cam/ncaml1,
atf3, and krox2-4/egr1 after intracortical but not after spinal axo-
tomy of layer V pyramidal neurons. In addition a recent study
revealed no changes in expression of the receptors for myelin-
associated inhibitor proteins in any neuronal population of the
mouse brain after severe T10 spinal cord contusion (Barrette et al.,
2007).
Until now, neither a systematic investigation on cortical gene
expression after SCI nor the molecular response to a regeneration-
promoting treatment in the injured CNS has been performed.
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Here, for the ﬁrst time, the questions (i) whether axotomized cor-
tical cells display a regeneration-associated gene expression pro-
gram upon therapeutic intervention and (ii) how this treatment-
triggered transcriptional program differs from the lesion-induced
response are addressed.
Previouswork in our lab showed that transient scar suppression
by local application of an anti-scarring treatment (AST) using an
iron chelator and cyclic AMP enabled long distance axon growth
and functional improvement after dorsal hemisection of the CST
(Klapka et al., 2005; Brazda and Müller, 2009). In addition, AST
treatment rescued pyramidal cells in layer V of the sensorimo-
tor cortex that project into the lesioned CST, thus preventing the
injury-induced loss or atrophy of up to 40% of this cell popula-
tion as described by Hains et al. (2003). Hence, AST treatment
not only promoted axon regeneration through the ﬁbrous scar at
the lesion site, but also exerted retrograde neuroprotective effects
on lesioned cortical neurons (Klapka et al., 2005). The beneﬁcial
effect of scar suppression on functional recovery in SCI has inde-
pendently been proven by other labs using different therapeutic
approaches (Davies et al., 2006; Tian et al., 2006; Ito et al., 2009).
Affymetrix microarray technology was applied to character-
ize transcriptional responses of sensorimotor cortex to SCI and
AST. We made use of adult rat in three experimental paradigms
including (i) sham-operated, (ii) lesion-only, and (iii) AST-treated
animals, at distinct time-points after lesion investigating the fol-
lowing stages: acute (1 day), early subacute (7 days), late sub-
acute (21 days) and chronic injury (60 days). We identiﬁed a
large number of lesion-triggered as well as AST-affected regu-
lated genes as early as 1 day after CST-axotomy. Our data indicate
dynamic and treatment-speciﬁc gene regulation patterns associ-
ated with distinct functional groups of genes involved in axonal
outgrowth/guidance or apoptosis/cell survival. The data further
demonstrate a remarkable AST-induced switch in the genetic pro-
gramof the affected sensorimotor cortex toward a neuroprotective
and growth-promoting state.
MATERIALS AND METHODS
TREATMENT PARADIGMS AND ANIMAL GROUPS
To study changes in neocortical mRNA expression after axotomy
of the CST in the thoracic spinal cord and to identify alterations
in gene expression due to AST, three groups of adult rats were
examined and compared (i) Sham-operated animals underwent
laminectomy but did not receive a SCI, (ii) Lesion-only animals
received a dorsal spinal cord hemisection including CST transec-
tion, (iii)AST-treated animals received a CST transection followed
by AST resulting in regenerative reactions. The animals were sac-
riﬁced at 1, 7, 21, or 60 dpo. Groups of three to ﬁve animals per
condition were analyzed. However, samples were not pooled so
each animal was used to generate an individual probe that was
hybridized to a separate microchip. Further considerations con-
cerning replicate numbers and pooling strategies have previously
been described in more detail (Kruse et al., 2008).
SPINAL CORD INJURY
Spinal cord injury was carried out as previously described (Klapka
et al., 2005). Brieﬂy, laminectomy of vertebrae Th8 and Th9 was
performed under isoﬂurane–anesthesia. The dura was opened
with spring scissors and the dorsal columns and dorsal CST were
cutwith a ScoutenWireKnife (Bilaney,Düsseldorf,Germany). The
iron chelator 2,2′-bipyridine-5,5′-dicarboxylic acid (BPY-DCA,
40mM in Tris-buffer) was injected both into the lesion site (four
injections of 0.2 μl) and at 1mm proximal to the lesion site (two
injections of 0.2 μl). After injection, 2mg of 8-Br-cAMP were
applied onto the lesion area. Control animals received injections of
Tris-buffer. Lesions of treated animals were covered with a piece
of ELVAX (ethylene–vinyl-acetate) copolymer sheet loaded with
BPY-DCA for slow release, whereas ELVAX copolymer in control
animals containedTris-buffer alone. The animalswere treatedwith
antibiotics (Baytril) for 1week after surgery and, if necessary, the
bladders were emptied manually. Over all locomotor behavior of
the rats was monitored using the open ﬁeld test. Analogous to the
results recently described (Klapka et al., 2005) theAST-treated ani-
mals showed moderate but signiﬁcant improvement in their BBB
score compared to lesion-only animals at 60 days post lesion (data
not shown). Animal experiments were all done in compliance with
current German legislation on animal research and have previ-
ously been approved by the State Ofﬁce for Nature, Environment
and Consumer Protection of North-Rhine-Westphalia (LANUV
NRW).
CORTICAL TISSUE PREPARATION AND TOTAL RNA ISOLATION
Initially, the appropriate cortical area for tissue preparation of
pyramidal cells in layer V of the sensorimotor cortex was deter-
mined by retrograde labeling with DiI (Figure 1A). For tissue
preparation, the brains were removed in a cold room (∼4˚C)
immediately after sacriﬁce and directly frozen in isopropanol at
−45 to −55˚C. Using a cryotom, 40 serial coronal brain slices
of 50μm thickness were cut from sham-operated, spinal injured,
and AST-treated spinal injured adult rats. The area of layer V
containing the primary motor neurons and the subjacent part of
layer VI were rapidly dissected at −20˚C and collected in Qiazol.
Total RNA was isolated using the RNeasy Lipid Tissue Mini Kit
(Qiagen, Hilden, Germany) completed by an additional DNAse-
I treatment to avoid genomic DNA contamination. Quality and
integrity of total RNA preparation was ﬁnally conﬁrmed using a
2100 Bioanalyzer System (Agilent Technologies, Santa Clara, CA,
USA).
PROBE LABELING, ARRAY HYBRIDIZATION, AND DATA ANALYSIS
GeneChip® Rat Expression 230A analysis was performed accord-
ing to the manufacturer’s protocol (Affymetrix, Santa Clara
CA, USA). Brieﬂy, 2μg of total RNA of each preparation
were converted into labeled cRNA, subsequently fragmented,
and hybridized to microarrays. Digitized signal intensities and
raw data quality were independently evaluated and then the
data were analyzed using ArrayAssist 4.2.0 software (Strata-
gene,Amsterdam,Netherlands) applying ﬁve different algorithms:
MAS5.0 (Affymetrix, 2001), MBEI (Li and Wong, 2001), PLIER
(Affymetrix, 2005), RMA (Irizarry et al., 2003a,b), and GCRMA
(Wu and Irizarry, 2004). After variance stabilization (+16) and
log-transformation (base 2) statistical analysis was carried out
using ANOVA calculations. To specify the time point and experi-
mental condition at which a particular gene is regulated post hoc
tests were applied. The thresholds to assign genes to be regulated
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FIGURE 1 | (A)Tissue preparation procedure: (i) representation of the
cortical area labeled by the retrograde tracer DiI. This area represents the
sensorimotor cortex containing neurons lesioned by the SCI paradigm. (ii)
Schematic representation of frontal serial brain sections with the area
indicated where DiI labeled neurons were found. (iii) Histological section of
the cerebral cortex, showing DiI-traced neurons in layer V. (B) Schematic
representation of rat CNS including the three experimental paradigms of
the present investigation. Descending CST axons originating in pyramidal
neurons of the cerebral cortex layer V are cut at spinal level Th8. Cortical
tissue from sham-operated, CST-lesioned, and AST-treated animals was
collected and analyzed.
were >1.3 (fold-change) and <0.02 (p-values). Genes were
considered signiﬁcantly regulated if they fulﬁlled the given criteria
by at least two algorithms, including either PLIER or GCRMA.
Further detailed information on data analysis can be found in
Kruse et al. (2008).
QUANTITATIVE POLYMERASE CHAIN REACTION PROCEDURES
Ampliﬁcation primers for real-time PCR analysis of the transcripts
of gm-csf, bag1, kalrn, prdx2, vdr, diablo, egr2, stxbp1, robo1, unc5A,
nrp1, gal, and gdnf were designed by using Primer Express 2.0
Software (Applied Biosystems, Foster City, CA, USA) and subse-
quently tested for efﬁciency and speciﬁcity. Real-time quantitative
polymerase chain reaction (qPCR) was performed by using SYBR
green chemistry (Applied Biosystems) and relative changes in
gene expression were determined using the ΔΔCt method (Livak
and Schmittgen, 2001) with ornithine decarboxylase1 (odc1) and
glyceraldehyde-3-phosphate dehydrogenase (gapdh) as reference
genes. Primer sequences are available upon request.
OVER- AND UNDER-REPRESENTATION IN FUNCTIONAL GROUPS AND
OVERLAPS
To extract relevant functional information fromour high through-
put analysis we used the gene ontology (GO) annotation sys-
tem (Ashburner et al., 2000) implemented in PathwayArchitect
(Stratagene) to identify GO-terms with unbalanced distribution
of a query list compared to a computed background, e.g., all probe
sets on the rat 230A-microarray. This enrichment analysis was
used to determine over- and under-represented functional groups
of regulated genes. The same procedure was also applied to detect
over- and under-representation of functional groups in overlaps
between time point-, treatment- and direction of regulation-
speciﬁc sets of genes. The level of signiﬁcance was calculated
via the hypergeometric distribution and corrected for multiple
testing.
RETROGRADE TRACING OF PYRAMIDAL NEURONS IN PRIMARY
SENSORIMOTOR CORTEX
Cortical pyramidal neurons were identiﬁed by injection of
2× 0.5μL of Fluoro-Gold (Fluorochrome LLC,Denver, CO,USA;
3% in ddH2O) lateral to the CST at the most proximal end of seg-
ment Th7 using a 10-μL Hamilton syringe with a 32-gage canula.
After 7 days the brains of traced animals were dissected either for
calibration of the cortical tissue preparation technique or for cell
identiﬁcation in combination with immunohistochemistry.
IMMUNOHISTOCHEMISTRY
Rats were transcardially perfused with 4% paraformaldehyde and
brains were subsequently post-ﬁxed in 4% paraformaldehyde, cry-
oprotected in 30% sucrose and 20μm thick sections were cut
on a cryostat. After microwave antigen retrieval in 10mM citrate
buffer (600W for 3× 2min) and blocking with 5% donkey-serum
(Sigma-Aldrich, St. Louis, MO, USA) in PBS-T (PBS with 0.1%
TritonX-100), the sections were incubated at 4˚C over-night with
either rabbit anti-galanin (1:100; Afﬁnity BioReagents, Rockford,
IL, USA), rabbit anti-VDR (1:750; Afﬁnity BioReagents, Rock-
ford, IL, USA), rabbit anti-GM-CSF (1:25; Santa Cruz Biotech-
nology, Inc., Santa Cruz, CA, USA), rabbit anti-Diablo (1:100;
Calbiochem,Darmstadt,Germany), rabbit anti-EGR2 (1:25; Santa
Cruz Biotechnology Inc., Santa Cruz, CA, USA), or mouse anti-
claudin-11 (1:1000; Abcam plc, Cambridge, UK) diluted in block-
ing solution. Alexa488-conjugated donkey anti-rabbit or donkey
anti-mouse secondary antibodies (1:200 each; Invitrogen, Carls-
bad, CA, USA) were used for visualization. After two washing
steps and elimination of lipofuscin autoﬂuorescence with 0.3%
Sudan Black B (in 70% ethanol, 7min at room temperature), the
sections were mounted with FluoromountG (Southern Biotech,
Birmingham, AL, USA). Since the Fluoro-Gold signal in retro-
gradely traced pyramidal neurons of sensorimotor cortex (see
above) gets lost during the subsequent immunohistochemical pro-
cedures, the sections were photographed before and after immune
staining at identical positions using a BZ-8000 digital microscope
(Keyence, Osaka, Japan).
RESULTS
CORTICAL GENE EXPRESSION PROFILES FOLLOWING SPINAL CORD
INJURY
It has been shown previously (Klapka et al., 2005; Schiwy et al.,
2009) that the CST, among other descending motor ﬁber tracts
in the injured rat spinal cord, responds to local AST by enhanced
regenerative axon growth. In order to characterize the tempo-
ral changes in cortical mRNA expression proﬁle after thoracic
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CST transection we compared the transcriptomes from cortical
layer V of AST-treated rats to those of sham-operated animals
(Figure 1B). We systematically identiﬁed signiﬁcantly regulated
genes comprising speciﬁc molecular responses over a period of 1,
7, 21, and 60 dpo (Table 1). Out of a total of ∼11,000 rat genes
represented on the microchip, approximately 3,100 genes were sig-
niﬁcantly regulated, at least at one of the time-points examined.
Despite of the distance between the lesion site at Th8 and the cor-
responding sensorimotor cortex (several centimeters), 521 genes
underwent signiﬁcant regulation in cortical layerV as early as 1 day
after transection. Later (7–60 dpo), the number of regulated genes
further increased and a maximum of 1,199 genes was reached at
21 days after injury. Notably, the proportion of up- and down-
regulations varied over time. While at 1, 7, and 60 dpo almost
equal proportions of the genes were up- or down-regulated, at
21 dpo the majority (73%) of the regulated genes were repressed
(Table 1).
THE LESION-TRIGGERED GENE EXPRESSION PROFILE IN
SENSORIMOTOR CORTEX IS ALTERED BY LOCAL SPINAL
ANTI-SCARRING TREATMENT
In order to determine AST-induced cortical gene regulations we
compared (i) the transcriptomes of cortical layer V of injured but
untreated (lesion-only) rats to that of sham animals (Lesion vs.
Sham comparison), and (ii) the transcriptome of AST-treated rats
to that of lesion-only animals (AST vs. Lesion comparison). Direct
comparisonof gene expression inAST-treated animalswith lesion-
only rats revealed a strong modulation of lesion-triggered gene
expression proﬁles by AST (Table 1). Similar to lesion-only ani-
mals, the number of signiﬁcantly regulated genes in AST-treated
animals increased over time reaching a peak at 21 dpo (1167 genes,
Table 1). During the entire period of 1–60 dpo approximately 2800
genes were signiﬁcantly altered in treated rats when compared to
lesioned animals. While at 1 dpo only 25% of the 430 signiﬁcantly
regulated genes in AST animals were up-regulated, nearly 70% of
the 732 regulated genes were up-regulated at 7 dpo. Interestingly,
the total number of regulated genes at each time point was similar
in lesion-only and AST animals.
Time- and treatment-speciﬁc changes in gene expression patterns
We observed four different types of AST-triggered alterations
of the lesion-induced gene expression proﬁle (Figure 2).
These included gene regulations in AST animals showing (i)
no signiﬁcant differences compared to lesion-only animals
(injury-speciﬁc gene regulation), (ii) an additional effect of the
AST treatment into the same direction of regulation as observed
in lesion-only animals (gene expression boosted by AST), (iii)
a counter-regulation back to or beyond the basal sham expres-
sion level (genes counter-regulated by AST), and (iv) AST-speciﬁc
alterations not observed in lesion-only animals (AST-speciﬁc
regulation). Interestingly, the group of AST-boosted probe sets
comprised only a very small proportion (∼1%) of the regulated
transcripts at all time-points examined. In contrast, the proportion
of AST-counter-regulated transcripts clearly increased over time
to more than 15% (Figure 2). The proportion of AST-speciﬁc
transcripts of the overall detected regulated probe sets was rather
high (40–46%, Figure 2). At each time point the numbers of
injury-speciﬁc and of AST-speciﬁc regulated transcripts were very
similar.
Identiﬁcation of time- and treatment-speciﬁc clusters of regulated
genes
Temporal comparison revealed a rather low overlap (<20%) of
regulated genes between consecutive survival time-points indicat-
ing dynamic changes in temporal regulation proﬁles which specify
different acute and chronic stages. For further insight into the
complexity of stage-speciﬁc gene regulation patterns, we inves-
tigated signiﬁcant temporal overlaps between genes regulated by
injury and/or AST throughout all time-points examined. If the
numbers of genes that were co-regulated at certain experimen-
tal conditions signiﬁcantly exceeded or fell short the number of
overlaps expected merely by chance, those co-regulated clusters
of genes were considered to be over- or under-represented in the
given experimental condition. For better visualization of distinct
responses showing high temporal overlaps of sets of regulated
genes we converted the data (Table S1 in Supplementary Mater-
ial) into a topographic map (Figure 3). Certain of these over- or
under-representations might be expected, as, e.g., in one exper-
imental condition genes cannot be up- and down-regulated at
the same time. In such a case the overlaps will be zero as indi-
cated by a dark blue pit. Additional dark blue areas denote the
low amount of AST-boosted regulations. On the other hand,AST-
triggered counter-regulations were very common and occurred
at all time points, leading to ridge-like structures. For example,
Table 1 | Numbers of regulated genes in sensorimotor cortex of sham, lesioned-only and AST-treated rats at four different time points (1, 7, 21,
60days) after surgical treatment.
Total Lesion vs. sham AST vs. lesion
Regulated Up(%) Down (%) Regulated Up (%) Down (%)
1 dpo 917 521 41 59 430 25 75
7 dpo 1404 853 44 56 732 68 32
21 dpo 2035 1199 27 73 1167 55 45
60 dpo 1582 959 56 44 866 51 49
The numbers and proportions of up- and down-regulated genes are shown. While the numbers of regulated genes identiﬁed at each time point were very similar for
the lesion and AST group, a strong imbalance of up- vs. down-regulations was observed at 1 and 7 dpo in the AST group and at 21 dpo in the lesion-only group.
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FIGURE 2 | Schematic representation of expression changes in
lesion-only animals compared to sham animals and in AST animals
compared to lesion-only animals illustrates the various regulation
patterns. In comparison to lesion-induced regulations, AST-induced
regulations showed four different responses: (i) probesets “Regulated by
injury” are strictly altered by SCI regardless of an additional AST treatment (no
signiﬁcant regulation in the comparison AST vs. Lesion); (ii) “Boosted by
AST” are probesets with altered expression by injury that become further up-
or down-regulated by AST; (iii) “Counter-regulated by AST” represents
probesets which are regulated back to or beyond sham-level by AST; (iv)
probesets “Exclusively regulated by AST” show no signiﬁcant Lesion vs.
Sham regulation. The detailed view on the right illustrates the results of all the
ﬁve implemented algorithms (Mas5, LiWong, Plier, RMA, and GCRMA) for
each comparison (Kruse et al., 2008).
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FIGURE 3 | “Topographic” map illustrating overlaps between sets of
regulated genes with respect to kind of treatment, direction of
regulation, and time point of the respective gene regulation. Overlaps
between groups of regulated genes for each time point, direction of
regulation, and the comparison of Lesion vs. Sham and AST vs. Lesion have
been calculated. The given number of overlaps is shown as percentage of
the expected number of overlaps. Overlaps smaller than 150% of the
expectancy value are illustrated in light to dark blue, over-representations in
overlaps higher than 150% of the expectancy value are illustrated in light to
dark red. For example AST-counter-regulations of lesion-induced genes at 7
and 21 dpo lead to the ridge structure in the lower left and in mirror image
in the upper right corner of the topographic map. The corresponding values
of the over- or under-representations including the level of signiﬁcance are
shown in Table S1 in Supplementary Material.
the lesion-triggered up-regulations at 7 and 21 dpo which are
counter-regulated in AST animals are shown as very prominent
ridges in the lower left corner of Figure 3. A similar strong overlap
between counter-regulated gene clusters is observed between genes
that are down-regulated in lesioned animals but up-regulated by
AST at 7 and 60 dpo. Many of the AST-counter-regulated genes
at 7 dpo could be attributed to the signiﬁcantly enriched func-
tional category of developmental processes including, e.g., mam-
malian achaete-scute homolog 1 (mash1), homeobox gene hoxA1,
granulocyte-macrophage-colony stimulating factor (csf2/gm-csf),
and others.
Another notable observation was the singular sharp peak rep-
resenting a signiﬁcant cluster of genes up-regulated at 21 dpo in
lesioned animals that showed a delayed upregulation in AST ani-
mals at 60 dpo. Among the genes that showed this AST-triggered
temporal shift in expressionwe found, e.g., fas apoptotic inhibitory
molecule 2 (faim2), claudin-11 (cldn11), peroxisome prolifera-
tive activated receptor delta (ppard), dihydropyrimidinase-like 5
(dpysl5/crmp5), bcl2-like 1 (bcl2l1/Bclx), statin-like (stnl/eef1a2),
syntaxin binding protein 1 (stxbp1), unc-5 homolog A (unc5A),
and the neuronal zinc-ﬁnger protein neuro-d4 (neuD4). The
observed clusters of counter-regulated genes and the tempo-
ral shift of co-regulated gene cluster demonstrate remarkable
differences in the regulatory control of repressed and induced
genes between the experimental conditions (lesion-only vs. AST-
treated).
DIFFERENTIAL REGULATION OF BIOLOGICAL PROCESSES
To reveal biological processes that were activated or repressed
following spinal cord lesion we assigned the regulated genes to
functional categories using the DAVID Bioinformatics Resources
(Dennis et al., 2003; Huang et al., 2009a). The stage-speciﬁc
enrichment of several functional groups of regulated genes indi-
cated the dynamic modulation of distinct cell physiological
responses following SCI (Table 2, upper half). At 1 dpo affected
processes included, among others, wounding responses, cytoskele-
tal reorganization, and cell survival, whereas at 7 dpo genes
involved in metabolic and transport processes, in oxidative stress
responses and brain development were predominantly changed.
At 21 and 60 dpo enriched regulation of functional groups
involved in protein biosynthesis and synaptic reorganization was
observed. Likewise, apoptotic processes were strongly modulated at
60 dpo.
The variety of biological processes that were predominant
in AST animals compared to lesion-only rats are summarized
in Table 2 (lower half). As in lesion-only animals the activa-
tion/repression of signiﬁcantly enriched functional groups of reg-
ulated genes appears to be stage-dependent in AST animals. While
genes involved in cell adhesion,motility,migration and nervous sys-
tem development were predominant at 7 dpo, affected processes
like, e.g., axon guidance, protein transport and vesicle transport,
Wnt signaling as well as acetylation/deacetylation (including epi-
genetic responses), and caspase regulatory activity (apoptosis/cell
survival) were enriched at 21 dpo. At 60 dpo processes compris-
ing transcription, protein biosynthesis/translation and, again, axon
guidance, acetylation/deacetylation as well as apoptosis/cell survival
were among the signiﬁcantly enriched functional categories. Some
important functional categories including nervous system devel-
opment, axon guidance, caspase regulatory activity/apoptosis, and
acetylation/deacetylation showed signiﬁcant enrichment in more
than one stage.AlthoughAST ratsmarkedly differed from lesioned
animals in the expression of 430 regulated cortical genes already at
1 dpo, no particular functional process was signiﬁcantly enriched
at this early time point. This indicates that AST treatment regu-
lated genes participating largely in the same biological processes
as those found in lesion-only animals.
To reveal the differential activation or repression of physi-
ological functions in response to regeneration-promoting AST
treatment as compared to lesion-only animals we analyzed which
GO-categories (Ashburner et al., 2000) were over- or under-
represented. Ontologies that did not exceed their stochastic expec-
tationwere not taken into account. A selection of themost affected
GO-categories is shown in Table 3. Many genes are part of sev-
eral GO-classes and may thus be involved in multiple functional
processes.
Interestingly, we observed clear differences between lesioned
and AST-treated animals, when we focused on genes linked to
apoptosis. While in lesion-only animals numerous genes respon-
sible for induction of apoptosis by extracellular signals via death
domain receptors were signiﬁcantly enriched in the group of up-
regulated genes, in AST-treated animals a large number of genes
of this subcategory was signiﬁcantly down-regulated. In addi-
tion, we observed enhanced representation of anti-apoptotic or
neuroprotective genes in treated animals. In these animals the
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Table 2 | Significantly enriched functional groups of regulated genes after SCI (upper panel) and after AST (lower panel).
LESION-TRIGGERED
Translation
Biosynthetic process
Response to oxidative stress Structural constituent of ribosome
Apoptosis Macromolecule metabolic process Cytoskeleton organization
Response to wounding Brain development Signal transduction Apoptosis
Protein folding Neurological process Synapse part Protein metabolic process
Cytoskeleton organization Glutamate receptor activity Ion channel activity Structural constituent of ribosome
Regulation of neurogenesis Neurotransmitter transport Postsynaptic membrane Synaptic transmission
AST-TRIGGERED
1 dpo 7 dpo 21 dpo 60 dpo
Cell motility Acetylation Acetylation
Cell adhesion Axon guidance Axon guidance
Cell migration Vesicle-mediated transport Structural molecule activity
Nervous system development Synaptic vesicle Gene expression
Protein transport Translation
Wnt signaling pathway Apoptosis
Nervous system development
Caspase regulator activity
Protein biosynthesis
Cellular metabolic process
number of up-regulated anti-apoptotic or neuroprotective genes
increased over time (Figure 4).
The GO-term cell morphogenesis also displayed striking differ-
ences between lesioned and AST-treated animals. The subcate-
gories axonogenesis and axon guidance were of particular interest.
Both groups were under-represented among lesion-induced genes
(+ 3) at all time-points examined (Figure 4). In contrast, in
AST-treated animals genes related to axonogenesis and axon guid-
ance were increasingly over-represented after treatment (Table 3;
Figure 4) indicating a regulatory functional switch in cortical
cells. The numbers of up-regulated genes in these two func-
tional subcategories were found to rise continuously. Through-
out the entire period from 1 to 60 dpo the temporal regulation
proﬁle of axon guidance associated genes changed from solely
down-regulation to predominant up-regulation in treated ani-
mals whereas genes related to axonogenesis showed AST-induced
up-regulation between 7 and 60 dpo (Figure 4).
Genes associated with membrane organization and biogenesis
were identiﬁed as over-represented in the up-regulated gene pools
of both lesioned and AST-treated animals (Table 4). Surprisingly,
we also found a signiﬁcant over-representation of up-regulated
structural constituents of myelin in AST-treated animals at 21 and
60 dpo (data not shown).
We further observed altered transcriptional and translational
activities in sensorimotor cortex after SCI, which were substan-
tially enhanced by AST treatment (Table 3). As shown in Figure 4
a high number of genes linked to the GO-term structural con-
stituent of ribosome was signiﬁcantly enriched in the group of
lesion-triggered down-regulations reaching a maximum num-
ber at 21 dpo. In contrast, AST-triggered up-regulation of genes
related to this category increased steadily up to 60 dpo. Interest-
ingly, at 21 dpo the majority of the down-regulated genes of this
functional category in lesioned animals was, at the same time,
counter-regulated in AST animals. A very similar temporal proﬁle
as shown for structural constituent of ribosome was observed for
the category transcription (Figure 4).
IDENTIFICATION OF REGULATED GENES ASSOCIATED WITH
AST-DEPENDENT RESPONSES
While one goal of this studywas to characterize novel transcripts in
sensorimotor cortex that were regulated as a response to traumatic
SCI, the second aim was to identify regulated genes that could play
a role in successful AST-promoted axonal regeneration.
Axon growth
Numerous known genes involved in axon growth in regenerat-
ing peripheral neurons were up-regulated in sensorimotor cortex
of AST-treated animals (Table 4) such as galanin (GAL), glial
cell derived neurotrophic factor (GDNF), kalirin (KALRN), LIM
domain only 4 (LMO4), galectin 1 (LGALS1), paternally expressed
3 (PEG3), serum/glucocorticoid regulated kinase (SGK), mitogen
activated protein kinase 8 interacting protein (MAPK8IP), actin
beta (ACTB), interleukins 4 and 6 (IL4, IL6), vitamin D3 recep-
tor (VDR), enabled homolog (ENAH), and S100 calcium binding
protein beta (S100B).
Important genes involved in axonal guidance also underwent
AST-triggered changes in expression. Among those genes were the
roundabout homolog 1 (robo1), reticulon 4 receptor (rtn4r/nogor),
unc-5 homolog A, B (unc5A, 5B), dihydropyrimidinase-like
5 (dpysl5/crmp5), paired-Ig-like receptor B (pirb), neuropilin
1 (nrp1), receptor-like tyrosine kinase (ryk), cyclin-dependent
kinase 5 (cdk5), semaphorin 6B (sema6b/semaZ ), contactin 2
(cntn2/tax1), neural cell adhesion molecule L1 (l1cam/ncaml1),
fasciculation and elongation protein zeta 1 (fez1), and activated
leukocyte cell adhesion molecule (alcam). Several of these genes
which are known to be involved in growth cone repulsion and/or
collapse, like robo1, unc5A and unc5B, dpysl5/crmp5, RTN4R,
pirb and nrp1, were down-regulated in AST-treated compared to
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Table 3 | A selection of significantly over- and under-represented functional groups of genes.
The ﬁrst column states the total number of genes on the chip associated with the corresponding functional group (right column) followed by the proportion (%)
of number of genes found/expected number of genes. The upper row shows the total number of regulated genes (overall, up- and down-regulated) in the given
comparison. The shades of gray indicate the signiﬁcance level calculated via the hypergeometric distribution. The names of the functional groups in the right column
are given as in the GO-tree.
lesion-only animals in at least one of the observed time points
(Table 4). On the other hand, genes like cntn2, fez1, and alcam,
which are positively involved in outgrowth and axonal pathﬁnd-
ing,were up-regulated in theAST group. Sema6b was up-regulated
in the cortex in AST-treated rats at 60 dpo.
Surprisingly, we neither found signiﬁcant cortical up-
regulation of gap43 in lesioned-only nor in AST-treated rats.
However, in treated animals we detected the sequential down-
regulation of the two transcripts fubp1 (far upstream element
binding protein 1) at 1 and 7 dpo and ptbp2 (polypyrimidine tract
bindingprotein 2) at 60 dpo (Table 4). These proteins are known to
interact with gap43 mRNA, thereby inﬂuencing its stability (Irwin
et al., 1997).
Apoptosis and protection
Numerous apoptosis-associated genes were regulated by AST
treatment (Table 4). Notably, genes known to be involved in
pro-apoptotic processes such as bcl2-like proteins 1 (bcl2l1/Bclx)
and 13 (bcl2l13), Nucleus accumbens-1 (nac1/btbd14b), direct
inhibitor of apoptosis-binding protein with low pI (diablo),
corticotropin-releasing hormone (crh), TNF receptor-associated
factor 2 (traf2), and neuronal death protein Dp5 (bid3/dp5) were
exclusively down-regulated in treated animals. On the other hand,
the group of genes encoding proteins with anti-apoptotic and/or
neuroprotective properties like protein kinase B (akt1), Bcl2-
associated athanogene 1 (bag1), peroxiredoxin 2 (prdx2), superox-
ide dismutase (sod1), colony stimulating factor 2 (csf2/gm-csf), and
signal transducer and activator of transcription 5A (stat5A/mgf),
were found to be up-regulated in AST animals compared to lesion
controls.
Development
Regeneration-promoting AST provoked induction of numerous
genes with known functions during development (Table 4),
including, amongst others, genes encoding for the DNA binding
proteins hand2 and hoxA1, the helix-loop-helix (HLH) inhibitors
of DNAbinding 1–3 (id1,2,3), the transcription factors runx1,hairy
and enhancer of split 1 (hes1) as well as the related repressor sharp1,
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FIGURE 4 | Selected functional groups of genes that were strongly
modulated by AST treatment.The number of signiﬁcant regulations
associated with the GO-terms axon guidance, axonogenesis, structural
constituent of ribosome, transcription, and anti-apoptosis throughout the
entire time period examined are shown (up-regulation: white bar;
down-regulation: gray bar). Note that the number of regulations related to
axon guidance which are altered by AST compared to lesion at 60 dpo alone
is higher than the total number of axon guidance genes regulated after
lesion-only over all time points.
the neurite growth-promoting factor 2 alias midkine (mdk),
the component of the neuron-speciﬁc chromatin remodeling
nBAF-complex Neuro-D4 (neuD4), and the fasciculation and
elongation protein zeta1 (fez1).
VALIDATION OF MICROARRAY EXPRESSION DATA BY QPCR
Weperformed real-timeqPCR to verify the validity of ourmicroar-
ray data. For most genes tested the qPCR data conﬁrmed our
microarray results, both in temporal pattern as well as in mag-
nitude of transcript regulation. The fold-change of regulation
Table 4 | Sensorimotor cortical regulations of selected genes in the
AST vs. Lesion comparison are displayed for selected functional
groups.
dpo Gene/protein name
1 7 21 60
OUTGROWTH/AXON GUIDANCE
↑ ↑ ↑ ↑ Galanin (GAL)
↑ ↑ Glial cell derived neurotrophic factor (GDNF)
↑ Activated leukocyte cell adhesion molecule
(ALCAM)
↓ Neural cell adhesion molecule L1 (NCAML1)
↑ Interleukin-6 (IL6)
↑ Interleukin-4 (IL4)
↓ ↑ Kalirin, RhoGEF kinase (KALRN)
↓ ↑ Microtubule-associated protein 1 A(Mtap1a)
↑ Mitogen activated protein kinase 8 interact-
ing protein (Mapk8ip)
↑ Early growth response 1 (EGR1, krox-24)
↓ ↓ Far upstream element binding protein 1
(FUBP1)
↓ Polypyrimidine tract binding protein 2
(PTBP2)
GROWTH INHIBITORY/REPULSIVE
↓ ↓ Neuropilin 1 (NRP1)
↓ ↑ Reticulon 4 receptor (RTN4R)
↓ ↓ Roundabout, axon guidance receptor,
homolog 1 (ROB01)
↓ ↑ unc-5 homolog B (UNC5B)
↓ ↑ unc-5 homolog A (UNC5A)
↓ ↓ Paired-lg-like receptor B (PirB)
↓ 3F8 chondroitin sulfate proteoglycan (Phos-
phacan, PTPRZ1)
↑ Semaphorin 6B (Sema6b)
SURVIVAL/ANTI-APOPTOTIC
↑ ↑ Vitamin D (1,25-dihydroxyvitamin D3) recep-
tor (VDR)
↑ ↑ v-akt murine thymoma viral oncogene
homolog 1 (Akt1)
↑ ↑ Colony stimulating factor 2 (CSF2)
↑ Signal transducer and activator of transcrip-
tion 5A (STAT5A)
↑ Ciliary neurotrophic factor (CNTF)
↓ ↑ Bcl2-like1 (BCL2L1)
↑ ↑ Peroxiredoxin 2 (PRDX2)
↑ Superoxide d ism utase 1 (SOD1)
↑ Bcl2-associated athanogene 1 (Bag1)
↑ Clusterin (CLU)
PRO-APOPTOTIC
↓ Diablo homolog (Diablo)
↓ ↓ Corticotropin-releasing hormone (CRH)
↓ BH3 interacting domain (Bid3)
↓ Tnf receptor-associated factor2 (Traf2)
↓ ↓ ↓ G protein a q (GNAQ)
(Continued)
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Table 4 | Continued
dpo Gene/protein name
1 7 21 60
DEVELOPMENT
↑ ↑ Heart and neural crest derivatives expressed 2
(Hand2)
↓ ↑ ↑ ↑ Midkine (neurite growth-promoting factor 2,
Mdk)
↑ ↑ Inhibitor of DNA binding 1 (ID1)
↑ Inhibitor of DNA binding 2 (ID2)
↑ Inhibitor of DNA binding 3 (ID3)
↑ HomeoboxAl (HoxA1)
↑ Hairy and enhancer of split 1 (Hes1)
↑ Runt-related transcription factor 1 (Runxl)
↓ ↑ Fas apoptotic inhibitory molecule 2 (FAIM2)
↓ ↑ Neuronal d4 domain family member (Neud4)
↑ ↑ Enhancer of split and hairy-related protein 1
(SHARP1)
↑ Fasciculation and elongation protein zeta 1 (Fez1)
The arrows indicate the signiﬁcant up- or down-regulation of the correspond-
ing gene at the given time points in AST compared to lesioned-only animals.
Next to genes involved in axonal outgrowth and guidance, survival and apoptosis
we detected a substantial number of cortically regulated genes associated with
development.
detected by qPCR was, in general, about 1.5–2 times higher than
in the array-based data. Genes from several relevant functional
groups were chosen for validation (Figure 5). Csf2/gm-csf, bag1,
kalrn, prdx2, vdr, egr2/krox20, robo1, unc5A, and gdnf showed
the same signiﬁcant regulation patterns with qPCR as with the
arrays. Galanin 1 (gal) and syntaxin binding protein (stxbp1) even
showed qPCR-based regulations at more time points than origi-
nally detected by microarrays. In the case of diablo and nrp1, the
signiﬁcance of the array-based regulation could be reproduced
for some but not all time points. In general, the qPCR analysis
conﬁrmed gene regulations observed by microarray analysis.
CELLULAR LOCALIZATION OF TRANSCRIPTS AND PROTEINS
In order to reveal cellular origins of transcripts of interest, we
consulted the public Allan database (Allen Brain Atlas; Lein et al.,
2007; http://mouse.brain-map.org/welcome.do). Fifty-nine tran-
scripts out of the 60 signiﬁcantly regulated genes mentioned in
this paper have been localized by in situ hybridization in sen-
sorimotor cortex. Of these transcripts, 49 could be classiﬁed
as of neuronal origin, and 44 of those were clearly found in
pyramidal cells of cortical layer V (Table S4 in Supplementary
Material). However, non-neuronal gene regulation from neigh-
boring glial and/or immune cells is also likely to be expected
in spinal injury- and treatment-affected sensorimotor cortex. We
further performed immunohistochemical localization of selected
proteins with different putative functions in regeneration, namely
proteins promoting axon outgrowth (Gal), neuronal maturation
and plasticity (Egr2/Krox20), neuroprotection (GM-CSF, VDR),
myelination (Egr2/Krox20, Cldn11), or, e.g., cell death (Diablo).
As shown in Figure 6 almost all of these proteins could be local-
ized in retrogradely labeled corticospinal neurons in layer V of
sensorimotor cortex. For GM-CSF and Galanin, localization in
pyramidal layerVneurons has not been described before. Depend-
ing on the particular intracellular distribution of these proteins,
we observed differential staining patterns.While the cytokineGM-
CSF (Figures 6A–C) and theneuropeptideGalanin (Figures 6G–I)
showed a homogeneous cytoplasmic localization in pyramidal
neurons, the spot-like distribution of Diablo in neuronal cyto-
plasm (Figures 6D–F) ﬁts well with its known mitochondrial
localization (Martinez-Ruiz et al., 2008). The immunostaining
of the transcription modulator vitamin D receptor (VDR), on
the other hand, was predominantly observed in the nucleus
of the pyramidal projection neurons (Figures 6M–O). Stain-
ing for the multifunctional C(2)H(2)-type zinc-ﬁnger transcrip-
tion factor Egr2/Krox20 revealed expression in somata and neu-
rites of cortical neurons, but failed to demonstrate additional
glial cell expression (Figures 6J–L). However, immunostaining
of the tight junction-related Claudin-11 protein revealed a non-
neuronal localization (Figures 6P–R) in cortical layer V and,
therefore, is an example for the contribution of non-neuronal
cells to spinal injury and treatment-triggered cortical gene expres-
sion. The Claudin-11 protein is part of the radial component
of CNS myelin which determines the permeability between lay-
ers of compact myelin (Bronstein et al., 1997; Morita et al.,
1999).
DISCUSSION
AXOTOMY OF THE CST LEADS TO SPECIFIC TEMPORAL GENE
EXPRESSION PROFILES IN CORTICAL LAYER V
To gain insight into cortical responses following SCI and
regeneration-promotingASTwehave investigated gene expression
proﬁles and their temporal changes in layer V of the sensorimotor
cortex of rat. We were able to demonstrate the highly complex
and extensive dynamic transcriptional reactions in sensorimotor
cortex following SCI. Furthermore, this analysis revealed extensive
neuroprotective and regeneration-promoting cortical responses to
local application of AST (Klapka et al., 2005).
Using microarray hybridization we identiﬁed 521 signiﬁcantly
regulated genes which showed a lesion-induced regulation as early
as 24 h after injury (see Table 1) indicating early cortical responses
to distant SCI. Each of the four pathophysiological stages follow-
ing SCI (acute, early, and late subacute, chronic) are characterized
by a distinct set of signiﬁcantly enriched functional groups of reg-
ulated cortical genes (see Table 2). Interestingly, many of the early
affected genes were related to wounding, apoptosis, neurogenesis,
and cytoskeletal reorganization suggesting their critical roles in the
initial response of the sensorimotor cortex to axotomy of the CST.
Over time, not only the numbers of regulated genes (see Table 1)
but also the number of enriched functional groups reﬂecting stage-
speciﬁc lesion-associated processes (see Table 2) further increased
in lesion-only animals reaching amaximumat 3weeks after injury.
Even after 60 dpo the cortical gene expression proﬁle in chronically
spinal injured animals still showed persisting alterations in more
than 900 genes compared to sham controls. The data obtained
from the Allan database (Table S4 in Supplementary Material) as
well as the immunostainings presented here (Figure 6) indicate
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FIGURE 5 |Validation of changes in mRNA expression by quantitative
qPCR for a subset of regulated cortical genes identified by the GeneChip
analysis. For selected time points the mRNA expression levels of cortical
tissues from either lesion-only (white bars) or AST- treated (black bars) were
compared to sham-operated animals. Abbreviations: early growth response 2
(EGR2), unc-5 homolog A (UNC5A), galanin (GAL), vitamin D receptor (VDR),
peroxiredoxin 2 (PRDX2), roundabout homolog 1 (ROBO1), colony stimulating
factor 2 (GM-CSF), Bcl2-associated athanogene 1 (BAG1), syntaxin binding
protein 1 (STXBP1), glial cell derived neurotrophic factor (GDNF), kalirin
(KALRN). Note: Signiﬁcance was calculated for the comparisons Lesion-only
vs. Sham-operated (corrected p-value <0.05*, <0.01**, <0.001***) and
AST-treated vs. Lesion-only (corrected p-value<0.05*, <0.01**, <0.001***).
predominant recordings of neuronal rather than non-neuronal
expression proﬁles in the examined spinal injury- or AST-affected
cortical layer V. Nevertheless, our data also revealed additional
non-neuronal gene regulations executed by neighboring cells, pre-
sumably glia, that contribute to the recorded cortical expression
proﬁles (see Figures 6P–R).
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FIGURE 6 | Cellular localization by immunohistochemistry of selected
proteins in coronal brain cryosections (20μm) of sensorimotor cortex
layerV. Retrogradely Fluoro-Gold (FG) labeled pyramidal neurons [FG/blue:
(B,E,H,K,N) and arrows in (Q)] showed positive immunoreactivity (green) of
GM-CSF (A,C), DIABLO/SMAC (D,F), GAL (G,I), EGR2 (J,L), and VDR
(M,O). While GM-CSF, GAL, and EGR2/KROX20 were homogeneously
distributed in the cytoplasm of retrogradely labeled injured pyramidal
neurons, Diablo showed a spot-like cytoplasmic distribution, whereas VDR
was mainly detected in the pyramidal cell nucleus. As expected, Claudin-11
(CLDN11) could not be localized in retrogradely FG-labeled cell bodies of
pyramidal neurons [see arrows in (P,Q,R)] but it was detected in
extraneuronal membranous structures [green: (P,R)]. Scale bars=50μm in
(A,D,G,J,M,P); 10μm in the insets.
AST TREATMENT STRONGLY MODIFIES THE LESION-INDUCED
CORTICAL GENE EXPRESSION PROFILES
Until now, studies on gene expression after CNS axotomy focused
on lesioned animals lacking therapeutic treatment. AST pro-
vides an excellent opportunity to investigate cortical gene expres-
sion under regeneration-promoting conditions. As shown here,
AST-induced rapid as well as long-lasting massive changes in
the lesion-triggered cortical gene expression proﬁle. Already at
1 dpo, 430 genes were differentially regulated in AST rats as
compared to the lesion-only control animals (see Table 1). This
AST-triggered modiﬁcation of the lesion response increased over
time peaking at 21 dpo. As outlined in Figure 2, we observed
several interesting responses. First, a substantial number of regu-
lated transcripts in lesion-only control animals were not changed
by AST, indicating that these regulations were triggered by SCI
regardless of treatment. Second, there was a group of injury-
triggered regulations that were boosted by AST, indicating that
some of the injury responses were already pointing into a support-
ive direction, but needed to be reinforced in order to stimulate
the regenerative process. Third, we noticed a very interesting
group of counter-regulated genes that increased with time. The
latter group of genes indicates that AST was able to reverse
numerous of the injury-induced regulations that presumably
could be harmful or detrimental for the regenerative process.
Finally, a surprisingly large proportion of transcript regulations
was AST-speciﬁc (∼42%) demonstrating a treatment-dependent
fundamental change toward a cortical regeneration-associated
program, rather than a slight modulation of the lesion-induced
gene expression proﬁle.
FUNCTIONAL CLASSIFICATION SUGGESTS A MODIFICATION OF GENE
EXPRESSION PROFILES TOWARD SURVIVAL AND AXON
GROWTH-PROMOTING PROCESSES BY AST.
Our study further reveals that numerous genes with known func-
tions during development show an AST-mediated induction (see
Table 4). For example, within the ﬁrst week of AST we could
demonstrate an early and sustained upregulation of hand2, encod-
ing a bHLH transcription factor with crucial functions in neuro-
genesis and survival of sympathetic neurons as well as in neu-
ronal differentiation (Doxakis et al., 2008; Schmidt et al., 2009).
Interestingly, midkine (mdk) encoding a heparin-binding factor
promoting growth, survival and/or migration of various target
cells (Michikawa et al., 1993; Owada et al., 1999; Zou et al., 2006)
and a critical factor in regeneration of injured peripheral nerves
(Sakakima et al., 2009) showed a biphasic AST-induced expres-
sion pattern with signiﬁcant upregulation starting at 7dpo. The
ID HLH proteins act as transcriptional regulators during develop-
ment and are generally considered asmodulators of differentiation
(Stewart et al., 1997; Norton et al., 1998). Similar to the AST-
induced regulation described in Table 4 Id-1, -2, and -3 showed
axotomy-induced up-regulation of expression also in peripheral
nerves (Gillen et al., 1995; Stewart et al., 1997; Bosse et al., 2006).
Furthermore, a very recent paper speciﬁed that id2 reprograms the
intrinsic growth state of adult DRG neurons and promotes neuri-
togenesis following SCI (Yu et al., 2011). Even later, at 21dpo, we
observed a distinct AST-mediated upregulation of developmental
genes like fez1, a gene required for the generation, differentia-
tion, and axon targeting of layer V corticospinal motor neurons
(Chen et al., 2005; Molyneaux et al., 2005) and involved in neu-
rite outgrowth (Miyoshi et al., 2003). The developmental and
neuron-speciﬁc regulator of Fas/CD95-mediated apoptosis faim2,
which exhibits neuroprotective potential in the context of neu-
rological diseases (Reich et al., 2011) shows a late AST-induced
upregulation. Furthermore, AST-induced developmental genes
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including, e.g., transcription factor mash1 and the homeobox gene
hoxA1 were repressed at 7 dpo after injury when a concomi-
tant regeneration-promoting treatment was lacking. Therefore,
our analysis suggests that, at least, partial and selective reactiva-
tion and maintenance of speciﬁc developmental responses could
be an important aspect of successful repair in both the PNS
(Vogelaar et al., 2003; Bosse et al., 2006) and the CNS, although
the repertoire of the re-induced developmental genes may be
different.
Well-regulated interactions with attractive or repulsive guid-
ance cues are important for successful axonal regeneration (for
review see Koeberle and Bähr, 2004; Bolsover et al., 2008; Curinga
et al., 2008). Accordingly,we observed anAST-triggered regulation
of genes involved in axon guidance/repulsion (down-regulation
of unc5A, unc5B, sema6b, reticulon 4 receptor) and axonogenesis
(up-regulation of gal, kalrn, egr1, mtap1a) in treated animals (see
Table 4). This group of genes became more prominent over time
and is likely to participate in AST-promoted regenerative axon
growth.
We further observed an AST-associated over-representation
of anti-apoptotic and an under-representation of pro-apoptotic
genes (see Tables 4) indicating that AST drives cortical gene
expression toward protective as opposed to cell death-promoting
pathways. These ﬁndings on themolecular level correlate well with
the previously published neuroprotective effects of AST (Klapka
et al., 2005). Interestingly, theAST-triggered changes in the expres-
sion of genes involved in apoptosis/cell survival occurred in a
biphasic mode at early (1 dpo) as well as late time points (60 dpo),
suggesting distinct phases of neural protection in the acute phase
and during later stages after injury and treatment (see Table 2).
REGULATED GENES WITH PROVEN FUNCTIONS IN AXONAL
REGENERATION
On the level of individual genes we could demonstrate that
genes positively involved in axon growth and guidance were pre-
dominantly up-regulated in AST animals throughout the entire
period studied (see Table 4). Conversely, transcripts encoding
growth inhibitory molecules were largely down-regulated. The
same observations were made in the groups of genes involved in
regulation of apoptosis/cell survival. While numerous survival-
promoting and anti-apoptotic genes were up-regulated, many
pro-apoptotic genes were down-regulated, especially at the early
time-point (see Table 4). Our data indicate that the statistical
calculations of over- and under-represented functional groups of
regulated genes in AST animals can, indeed, be conﬁrmed at the
level of individual genes with known functions.
Some regeneration-associated genes (RAGs), which are well
known in the context of peripheral nerve regeneration, were also
found in this CNS study. Galanin, for example, is up-regulated in
peripheral neurons after injury, and is regarded as a “regenerating
axon”marker (Villar et al., 1989; Suarez et al., 2006).We found per-
sisting up-regulation of galanin mRNA under AST conditions at
all time-points studied (see Figure 5), suggesting long-term sup-
port of central axon regeneration, which was corroborated by its
proven localization in pyramidal neurons of cortical layer V (see
Figure 6).
Midkine (Mdk), a heparin-binding growth factor, is implicated
in development and repair of various tissues, including the ner-
vous system. It has been reported that Mdk promotes peripheral
nerve regeneration (Sakakima et al., 2009), protects from focal
brain ischemia and augments central neurogenesis (Ishikawa et al.,
2009). Therefore, the long-lastingAST-triggered induction of mdk
(7–60 dpo) as observed here may indicate a critical role of mdk in
AST-induced neuroprotection and subsequent regeneration.
The relevance of vitamin D, a neuroactive seco-steroid, dur-
ing CNS development is also receiving increasing recognition
(Veenstra et al., 1998; Keisala et al., 2009). Its receptor (VDR)
belongs to the family of trans-acting transcriptional regulatory
factors, and genetic vdr ablation produces severe motor impair-
ment (Kalueff et al., 2004) conﬁrming the importance of the
vitamin D system in motor functions. Thus, it is likely that the
AST-mediated counter-regulation of vdr in pyramidal neurons
(see Figure 6) compared to the diminished expression after lesion
(see Figure 5) may also contribute to the beneﬁcial AST effect
after SCI.
GM-CSF is a cytokine that not only controls the production,
differentiation, and function of granulocytes and macrophages,
but also induces dose-dependent neuronal differentiation of
neural stem cells (Krüger et al., 2007). GM-CSF and its recep-
tors are broadly expressed throughout the brain and known to
be up-regulated after ischemic insults counteracting programmed
cell death (Schäbitz et al., 2008). Further,GM-CSF-administration
in a rat SCI-model resulted in signiﬁcantly reduced glial scar for-
mation and enhanced integrity of axonal structure (Huang et al.,
2009b). Thus, the early but sustained (1–21 dpo) AST-mediated
induction of csf2/gm-csf (see Figure 5) suggests a role both in the
rescue of pyramidal cells in cortical layer V where GM-CSF is
expressed (see Figure 6) as well as in successful regeneration of
CST axons as previously observed in AST animals (Klapka et al.,
2005).
The transcription factor c-Jun/AP-1 has been identiﬁed to be
differentially expressed after axotomy (Broude et al., 1997; Ken-
ney and Kocsis, 1997; Vaudano et al., 1998) and associated with
apoptosis in the nervous system (Herdegen et al., 1997). Consis-
tently, the AST-triggered counter-regulation of c-jun/ap-1 mRNA
in cortical neurons back down to sham levels as observed in the
present investigation could reduce putative pro-apoptotic effects
of c-Jun/AP-1 and thus support neuronal survival.
CONCLUSION
In this unique molecular systems investigation we observed that
cortical neurons are capable of dynamic responses on the tran-
scriptional level to SCI, and that they further modify their com-
plex lesion-triggered gene expression proﬁle in response to dis-
tant regeneration-promoting treatment (AST) in spinal cord.
We were able to correlate AST-promoted effects, namely retro-
grade neuronal protection, enhanced regenerative axon growth
and functional (locomotor) recovery, with signiﬁcant changes
in cortical gene expression proﬁles. Obviously, AST not only
modiﬁes the local environment impeding spinal cord regenera-
tion by reduction of ﬁbrous scarring in the injured spinal cord,
but, in addition, the treatment strikingly changes the intrin-
sic capacity of cortical pyramidal neurons toward enhanced cell
Frontiers in Molecular Neuroscience www.frontiersin.org September 2011 | Volume 4 | Article 26 | 13
Kruse et al. Cortical gene expression in SCI
maintenance and axonal regeneration. The data suggest that com-
bined administration of the iron chelator and cyclicAMP could
successfully facilitate axonal regeneration by (i) reducing the
accumulation of growth inhibitory factors at the lesion site, (ii)
modulating the immune response, (iii) increasing growth factor
availability, (iv) regulating cytoskeletal reorganization and pro-
tein synthesis, and (v) providing neuroprotection by sequestering
redox-active iron and thereby inhibiting the Fenton reaction as
well stabilizing the neuroprotective transcriptional activator HIF-
1α. Further detailed studies will be required in order to eluci-
date the essential molecular players and participating pathways
employed by AST treatment to improve axonal regeneration after
traumatic SCI.
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Table S1 | Overlaps between gene regulations in Lesion and AST paradigms at
different time points. The given overlap between groups of regulated genes is
shown as percentage of the number of overlaps merely expected by chance as
calculated from the group sizes and the total number of genes on the chip. Each
possible comparison for the time point-speciﬁc sets of up- and down-regulated
genes in the groups Lesion vs. Sham and AST vs. Lesion is illustrated. Overlaps
showing signiﬁcant over- or under-representation are shown in orange
(over-representation) and blue (under-representation), respectively. Interestingly,
some of the overlapping effects were prolonged over more than one time point.
For example a signiﬁcant proportion of lesion-induced genes detected at 1 dpo
was down-regulated by AST at 1 (259%) and also at 7 (331%) dpo.
Table S2 | Signiﬁcantly regulated genes showing AST-induced counter-regulation
or a temporal shift according to Figure 3. The respective regulated Probeset IDs
are shown.
Table S3 | Lists of signiﬁcantly regulated genes associated with the GO-terms
axon guidance, axonogenesis, structural constituent of ribosome, transcription,
and anti-apoptosis. The respective regulated Probeset IDs are shown. The
number of regulations for the comparison of AST vs. Lesion are shown in
Figure 4.
Table S4 | List of signiﬁcantly regulated transcripts identiﬁed in the present
investigation, which had previously been localized by in situ hybridization in layer
V cells of mouse sensorimotor cortex (see Allan Brain Atlas;
http://mouse.brain-map.org/welcome.do)
Figure S1 | Examples for cellular localization of selected transcripts by ISH in
sensorimotor cortex of rat as found in the mouse brain atlas of the Allen
Institute for Brain Science. Large pyramidal cell bodies in cortical layer V show
strong signals for nrp1 and robo1, repectively. Scale bars=100μm.
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